ArticleSleep medicine2022
Insomnia symptoms during the COVID-19 pandemic: an examination of biopsychosocial moderators.
Article in Sleep medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The Impact of the COVID-19 Pandemic on Latinx College Students' Mental Health: Exploring the Role of Sleep, Social Support, and AttitudinalClocks & sleep · 2026Article
- Feasibility of rTMS combined with dexmedetomidine in chronic insomnia disorder.Scientific reports · 2025Article
- Insomnia during the COVID-19 pandemic: prevalence and correlates in a multi-ethnic population Singapore.BMC public health · 2024Article
- Article
- Mid-to-Late-Life Anxiety and Sleep during Initial Phase of COVID-19: Age- and Sex-Specific Insights to Inform Future Pandemic Healthcare.Brain sciences · 2024Article
- The Mental Health of Poles during the COVID-19 Pandemic.International journal of environmental research and public health · 2023Article
- Factors Associated with Insomnia and Aggression among Healthcare Workers during COVID-19 Pandemic.International journal of environmental research and public health · 2023Article
- Insomnia symptoms predict longer COVID-19 symptom duration.Sleep medicine · 2023Article
- The unique contribution of depression to cognitive impairment in Post-Acute Sequelae of SARS-CoV-2 infection.Brain, behavior, & immunity - health · 2022Article
- Circadian disturbances, sleep difficulties and the COVID-19 pandemic.Sleep medicine · 2022Review
- An examination of racial and ethnic disparities in mental health during the Covid-19 pandemic in the U.S. South.Journal of affective disorders · 2021Article
- Increased use of digital tools in sleep disorders research in response to the COVID-19 challenge: implications for the present and future.Sleep medicine · 2021Article
- Insomnia Symptoms in the General Population During the COVID-19 Pandemic.Frontiers in psychiatry · 2021Article
- Understanding the Impact of the COVID-19 Pandemic, Lockdowns and Social Isolation on Sleep Quality.Nature and science of sleep · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
OBJECTIVE/
backgroundHealthy sleep is vital for physical and psychological health, and poor sleep can result in a myriad of negative physical and psychological outcomes. Insomnia symptoms often manifest as a result of acute life stressors or changes, and COVID-19 experiences may be one such stressor. Other known predisposing factors to insomnia may moderate the impact of COVID-19 experiences on sleep. The present study aimed to determine current levels of insomnia severity in a US sample, to investigate the relation of COVID-19 experiences to insomnia symptoms, and to determine which individuals are most susceptible to this association.
methodsData were drawn from a larger online survey investigating sleep and health outcomes across the lifespan. COVID-19 experiences were assessed with the exposure and impact subscales of the CAIR Pandemic Impact Questionnaire (C-PIQ). The Insomnia Severity Index (ISI) measured insomnia symptoms. Biological, psychological, and social moderators were measured using other brief self-report measures.
resultsInsomnia symptoms prevalence was as follows: moderate-to-severe symptoms (25.5%), subthreshold symptoms (37.7%), and no symptoms (36.7%). Individuals' COVID-19 experiences significantly predicted insomnia symptom severity [F(1,997) = 472.92, p < 0.001, R
conclusionsAlthough negative experiences with COVID-19 are associated with worse insomnia symptoms, this relationship is not the same for everyone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.